|
| Clinical and experimental research of Shenbaixiao Capsule on hyperlipemia of pediatric nephritic syndrome |
| Hits 1811 Download times 1451 Received:September 17, 2002 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2003.02.12 |
| Key Words
nephritic syndrome;treatment of TCM;Shenbaixiao Capsule |
| Author Name | Affiliation | | LI Zhao-feng | Pingyi Hospital of Traditional Chinese Medicine, Pingyi, Shandong 273300, China | | XU Qing-jie | Pingyi Hospital of Traditional Chinese Medicine, Pingyi, Shandong 273300, China | | JING Hua-min | Pingyi Hospital of Traditional Chinese Medicine, Pingyi, Shandong 273300, China | | 王金英 | Pingyi Hospital of Traditional Chinese Medicine, Pingyi, Shandong 273300, China | | 仇付丽 | Pingyi Hospital of Traditional Chinese Medicine, Pingyi, Shandong 273300, China |
|
| Abstract
|
| [Objective] To evaluate the effect of Shenbaixiao Capsule clinically and experimentally. [Method] Plasma viscos-ity,APTT,and urinary protein were detected and compared before and after treatment. [Result] In cases with high plasma viscosity,APTT was shortened markedly.APTT in treatment group was longer than that in normal control group but there was no obvious effect in control group.The recovery time of plasma viscosity,disappearance time of urinary protein and edema in treatment group was shorter than that in control group without causing bleeding. [Conclusion] There is hyperco-agulability in patients with hypervisicosity of nephritic syndrome.Shenbaixiao Capsule is safe and effective. |
|
|
|
|
|
|
|
